Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights by Seini Moimoi | Mar 15, 2022 | Portfolio News
Dascena Awarded NIH Grant to Reduce Bias in Acute Coronary Syndrome Diagnosis and Treatment by Seini Moimoi | Mar 9, 2022 | Portfolio News
Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare by Seini Moimoi | Mar 8, 2022 | Portfolio News
Inozyme Pharma Strengthens Management Team with Two Executive Appointments by Seini Moimoi | Mar 8, 2022 | Portfolio News
Axonics® Receives FDA Approval for Recharge-Free Sacral Neuromodulation System by Seini Moimoi | Mar 7, 2022 | Portfolio News
Lexeo Therapeutics Announces Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of AAA-Based Gene Therapy Candidate LX1001 in Patients with Alzheimer’s Disease by Seini Moimoi | Mar 2, 2022 | Portfolio News
